A detailed history of Kestra Advisory Services, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 24,000 shares of ANIX stock, worth $99,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,000
Previous 17,000 41.18%
Holding current value
$99,359
Previous $56,000 41.07%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$2.92 - $3.52 $20,440 - $24,640
7,000 Added 41.18%
24,000 $79,000
Q2 2025

Aug 14, 2025

SELL
$2.38 - $3.75 $69,020 - $108,750
-29,000 Reduced 63.04%
17,000 $56,000
Q1 2025

May 14, 2025

BUY
$2.13 - $3.29 $38,340 - $59,220
18,000 Added 64.29%
46,000 $131,000
Q4 2024

Feb 10, 2025

BUY
$2.48 - $3.97 $69,440 - $111,160
28,000 New
28,000 $69,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $127M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.